Browse All

Current Filters

CLEAR FILTER x

TITLE

Characterization of BHV-7000: A Novel Kv7.2/7.3 Activator for the Treatment of Seizures

Author:Picchione, Kelly   Resnick, Lynn   Bozik, Michael   Dworetzky, Steven   

Session Name:S29: Epilepsy Diagnostics and Therapeutics  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S29.006  

Author Institution:Biohaven Pharmaceuticals, Inc, New Haven, CT  

Phase 1 Study Evaluating the Safety and Tolerability of BHV-7000, a Novel, Selective Kv7.2/7.3 Potassium Channel Activator, in Healthy Adults

Author:Awsare, Bharat   Lerner, Jason   Ashbrenner, Eric   Sevinsky, Heather   Bozik, Michael   Dworetzky, Steven   Donahue, Lia   Killingsworth, Randall   Francoeur, Bruno   Qureshi, Irfan   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials and Outcomes  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.007  

Author Institution:Biohaven Pharmaceuticals, Inc, New Haven, CT  Syneos Health, Quebec, QC, Canada  

Novel, Selective Kv7.2/7.3 Potassium Channel Activator, BHV-7000, Demonstrates Dose-dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults

Author:Lerner, Jason   Awsare, Bharat   Sevinsky, Heather   Ashbrenner, Eric   Killingsworth, Randall   Kendrick, Racheal   Vereycken, Emiel   Colenbrier, Nigel   Neuray, Caroline   van Mierlo, Pieter   Slater, Jeremy   Wyatt, David   Qureshi, Irfan   Dworetzky, Steven   Bozik, Michael   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials and Outcomes  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.011  

Author Institution:Biohaven Pharmaceuticals, Inc, New Haven, CT  Certara, Inc, Princeton, NJ  Epilog, Clouds of Care NV, Ghent, Belgium  Stratus, Irving, TX  Syneos Health, Quebec, QC, Canada